Followers | 7 |
Posts | 1577 |
Boards Moderated | 0 |
Alias Born | 02/27/2014 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, May 11, 2015 9:07:12 AM
It accomplishes nothing as
1) nobody wants to invest in a stock that is worth 20% less by year end....and worth 50% less after 2 years
2) the company can never post a profit when stock grants are accounted for.
3) the company got little flexibility to raise capital at reasonable costs.
4) the company's reputation is very bad because of 1), 2) and 3)
Had the dilution been half of what it is, the employees stock holdings would be worth much more, as the stock price would be $20.
I would rather own 500 stocks worth $20, than 1000 stocks worth $4.
I would rather see Musclepharm taking a sufficient loan or raising capital for financing than executives having to pledge their personal stock holdings. It is all a result of the excessive dilution policy of the company, where more and more stocks are issued for nonsensical purposes that don't create any value whatsoever.
Somebody probably had seen enough of that, and after reading the Bloomberg article, he/she just pulled the trigger.
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM